It looks like nothing was found at this location. Maybe try one of the links below or a search?
Popular Articles:
-
Response to EPO consultation: Don’t impose oral proceedings by videoconference
-
Quality at the EPO – One Modest and one Serious Proposal
-
‘Opposition against Unitary Patent comes from fearful lawyers and critics who only have a theoretical interest’
-
Leading German patent law firms criticize European Patent Office
-
UPC: four reasons on why the PPA is not legally in force
-
The EPO’s Vision (V) – Trust
Recent Articles:
-
Announcement of the national program “MOVER” raises expectations for an increase in patent filings for green technology
-
UPC “saisie-contrefaçon” Part III: the “C-Kore” case
-
Brazil: Animal Health and Patent Litigation
-
China’s Supreme People Court decides FRAND dispute in ACT v Oppo
-
UPC “saisie-contrefaçon” Part II: the “OERLIKON” case
-
UPC “saisie-contrefaçon” Part I: the texts
Random Articles:
-
Patent case: BedGear LLC v. Fredman Bros. Furniture Co. Inc., USA
-
PDL Biopharma – humanized antibodies, European Patent Office (EPO Board of Appeal), 14 October 2009
-
EPO revokes Bayer broccoli patent
-
Napp v. Ratiopharm, Court of Appeal Civil Division (Court of Appeal Civil Division), 01 April 2009
-
IBSA Institut Biochimique SA v. Pharmacia & Upjohn in liquidazione and Pfizer Italia s.r.l., District Court Milan (Tribunale Milano), 26 May 2009
-
Actavis v. Merck, Court of First Instance Paris (Tribunal de Grande Instance Paris), 28 September 2010
-
Patent case: Edwards Lifesciences LLC v Boston Scientific Scimed Inc, United Kingdom
-
Parliamentary committee asks UK government to clarify position on Unified Patent Court
-
Added matter and omnibus claims: a UK perspective
-
The Fentanyl Decision – Lessons to be learned for Claim Construction and Novelty